Skip to main content
Uncategorized

Transbio partners present forum to boost new projects in molecular medicine and agrofood innovation

By 3 de September de 2013November 18th, 2020No Comments
< Back to news
Photo taken at the Barcelona Science Park, one of the partners in the new Transbio project - Photo: © Biocat, Raimon Solà.
 03.09.2013

Transbio partners present forum to boost new projects in molecular medicine and agrofood innovation

Partners in the Interreg Sudoe Transbio project are organizing the Transbio Emergence Forum to boost collaborative business and research projects among the regions in southwest Europe in the fields of molecular medicine and agrofood innovation, from 25 to 27 September in Montpellier (France). Transbio (2013-2014), the continuation of the Interbio project (2009-2012), aims to boost the transfer of health sciences research to market. A total of 32 bodies from eight regions in France, Portugal and Spain are participating, including Biocat, the Parc Científic de Barcelona (PCB), the UAB Research Park and CataloniaBIO from Catalonia.


The Transbio Emergence Forum is geared towards leaders and professionals from companies, technology transfer offices, research centers and science/technology platforms. This event will coincide with the Euromediag International Convention (EIC 2013) on medical diagnostics and personalized medicine, also in Montpellier.

Success stories in Montpellier

On 25 September there will be a field study with representatives of the Transbio project and businesspeople and executives from the Montpellier area analyzing the successes and hurdles they have experienced in starting up innovative companies and during business development. It will also include an example of groundbreaking funding in France to support the growth of biohealth companies, the Banque Publique d’Investissement.

Scientific program and B2B meetings

The forum will be held on 26 and 27 September with a scientific program and space for B2B meetings with an online support platform to schedule meetings. The plenary session entitled A novel and highly innovative treatment for the acute myocardial infarction, on 26 September at 8:30 am, will feature the unveiling of a treatment being developed by Vall d’Hebron University Hospital in Barcelona and Pierre Fabre laboratories. Twenty pitch sessions (5 minutes) by experts in molecular medicine will cover current topics.

Presentations from science platforms and TTO

The forum will also set aside a space for seven science/technology platforms to present their research-support services: from the Parc Científic de Barcelona (Drug Discovery), University of Santiago de Compostela, IPBS, European Institute of Chemistry and Biology (IECB), Prince Felipe Research Center (CIPF) in Valencia, the BIOIB and the French National Center for Scientific Research (CNRS). Additionally, four Technology Transfer Offices (TTO) —from the Vall d’Hebron Research Institute (VHIR) in Barcelona, the University of Santiago de Compostela, the Polytechnic University of Valencia and OTRI Toulouse— will explain their work and technology portfolios.